MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1186/s12890-025-04078-x

Медицинская библиотека · BMC pulmonary medicine · 2026

Effects of combined inspiratory muscle training and positive expiratory pressure therapy on pulmonary function, respiratory muscle strength, exercise capacity and dyspnea in stable group E COPD patients.

Jalal Latifullah, Aksakal Alperen, Kerget Buğra, Uçar Elif Yılmazel, Araz Ömer, Sağlam Leyla, Akgün Metin

СтатьяРандомизированное исследованиеПеревод пока не подготовлен

Аннотация

BACKGROUND

Inspiratory muscle training combined with positive expiratory pressure (IMT/PEP) may improve outcomes in chronic obstructive pulmonary disease (COPD), but evidence in exacerbation‑prone (Group E) disease is limited. We evaluated the effects of IMT/PEP on pulmonary function, respiratory muscle strength, exercise capacity, and dyspnea in stable Group E COPD.

METHODS

In this prospective randomized controlled trial, 62 stable Group E COPD patients were enrolled from June 2023 to September 2024 and randomized to IMT/PEP plus standard care or standard care alone. Pulmonary function tests, maximal inspiratory pressure (MIP), maximal expiratory pressure (MEP), six‑minute walk test (6MWT), oxygen saturation (SpO₂), and dyspnea scales (mMRC, CAT, MBS, VAS) were assessed at baseline, 1 month, and 3 months.

RESULTS

At 1 month, compared with controls, the IMT/PEP group showed greater improvements in FEV₁/FVC, FEV₁, and FVC (all p < 0.001), a smaller increase in RV/TLC (p < 0.001), and higher SpO₂ and 6MWT distance (both p < 0.001); MIP also increased (p = 0.01). By 3 months, FEV₁/FVC (p = 0.02), FEV₁ (L and % predicted; p = 0.01 and p = 0.04), FVC (L and % predicted; p = 0.04), and MEF25–75% (p = 0.01) were higher and RV/TLC was lower (p = 0.01) in the IMT/PEP group; MIP increased in absolute and % predicted terms (p = 0.001 and p = 0.002), whereas MEP did not change significantly. SpO₂ and 6MWT increased (both p < 0.001), and MBS, mMRC, VAS, and CAT scores decreased (p < 0.001 for each). In multivariable analyses, greater ΔMIP was associated with lower baseline MIP (p < 0.001), lower baseline 6MWT (p = 0.033), lower baseline VAS (p = 0.016), and higher baseline MEP (p = 0.001).

CONCLUSIONS

In stable Group E COPD, adjunct IMT/PEP improved pulmonary function (FEV₁, FVC, FEV₁/FVC, MEF25–75%, RV/TLC), inspiratory muscle strength, oxygenation, and exercise capacity and reduced dyspnea over 3 months; benefits were most pronounced in patients with lower baseline inspiratory strength and limited functional capacity. TRIAL REGISTRATION: Registered at ClinicalTrials.gov (NCT07001462) on 3 June 2025. Retrospectively registered.

Для цитирования: Jalal Latifullah, Aksakal Alperen, Kerget Buğra, Uçar Elif Yılmazel, Araz Ömer, Sağlam Leyla, Akgün Metin. Effects of combined inspiratory muscle training and positive expiratory pressure therapy on pulmonary function, respiratory muscle strength, exercise capacity and dyspnea in stable group E COPD patients.. BMC pulmonary medicine. 2026. DOI: 10.1186/s12890-025-04078-x.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.